|
gptkbp:instanceOf
|
anabolic steroid
|
|
gptkbp:administeredBy
|
intramuscular injection
|
|
gptkbp:alsoKnownAs
|
1-dehydrotestosterone
Δ1-testosterone
|
|
gptkbp:ATCCode
|
A14AA08
|
|
gptkbp:bannedIn
|
gptkb:World_Anti-Doping_Agency
|
|
gptkbp:CASNumber
|
846-48-0
|
|
gptkbp:chemicalFormula
|
C19H26O2
|
|
gptkbp:derivedFrom
|
testosterone
|
|
gptkbp:effect
|
stimulates erythropoiesis
increases appetite
increases muscle mass
|
|
gptkbp:eliminationHalfLife
|
14 days (as undecylenate ester)
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
boldenone
|
|
gptkbp:isNotApprovedFor
|
human use in the United States
|
|
gptkbp:legalStatus
|
controlled substance in many countries
|
|
gptkbp:marketedAs
|
gptkb:boldenone_undecylenate
|
|
gptkbp:marketedUnderBrandName
|
gptkb:Equipoise
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
286.41 g/mol
|
|
gptkbp:PubChem_CID
|
9048
CHEMBL1200980
|
|
gptkbp:relatedTo
|
gptkb:nandrolone
testosterone
|
|
gptkbp:sideEffect
|
acne
voice changes
increased hair growth
oily skin
increased libido
suppression of natural testosterone production
|
|
gptkbp:UNII
|
Q06QI55Y9A
|
|
gptkbp:usedIn
|
gptkb:veterinary_medicine
|
|
gptkbp:bfsParent
|
gptkb:Boldenone_undecylenate
gptkb:boldenone_undecylenate
|
|
gptkbp:bfsLayer
|
7
|